4grw:H (GLU1) to (SER123) STRUCTURE OF A COMPLEX OF HUMAN IL-23 WITH 3 NANOBODIES (LLAMA VHHS) | CYTOKINE, IMMUNOGLOBULIN FOLD, VHH DOMAIN, IMMUNE SYSTEM
1a0q:L (ILE2) to (ALA109) 29G11 COMPLEXED WITH PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL] PHOSPHONATE | CATALYTIC ANTIBODY, ESTERASE
2otu:C (LEU2) to (VAL114) CRYSTAL STRUCTURE OF FV POLYGLUTAMINE COMPLEX | ANTIBODY FV POLYGLUTAMINE COMPLEX, IMMUNE SYSTEM
4ww1:B (VAL4) to (GLU125) CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 AND BETA CHAIN-TRBV7-8 | IMMUNITY, NKT CELLS, IMMUNE SYSTEM
2p5e:E (GLY1) to (GLU112) CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY | T-CELL RECEPTOR, CDR3, PHAGE DISPLAY, MUTANT, HIGH AFFINITY, NY-ESO- 1, IMMUNE SYSTEM
1bd2:E (GLY3) to (GLU118) COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201 | COMPLEX (MHC-VIRAL PEPTIDE-RECEPTOR), COMPLEX (MHC-VIRAL PEPTIDE- RECEPTOR) COMPLEX
3ezj:H (GLN1) to (SER120) CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF THE SECRETIN GSPD FROM ETEC DETERMINED WITH THE ASSISTANCE OF A NANOBODY | GENERAL SECRETORY PATHWAY, SECRETIN, SINGLE CHAIN ANTIBODY, PROTEIN TRANSPORT, IMMUNE SYSTEM, COMPLEX
2bse:E (GLN3) to (SER123) STRUCTURE OF LACTOCOCCAL BACTERIOPHAGE P2 RECEPTOR BINDING PROTEIN IN COMPLEX WITH A LLAMA VHH DOMAIN | LACTOCOCCUS LACTIS, PHAGE, RECEPTOR BINDING PROTEIN, LLAMA ANTIBODY, VHH, RECEPTOR
3s96:B (VAL243) to (VAL354) CRYSTAL STRUCTURE OF 3B5H10 | FAB, HUNTINGTIN, IMMUNE SYSTEM
1oga:D (GLN3) to (PRO111) A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION. | IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM/RECEPTOR/COMPLEX, TCR, MHC, IMMUNODOMINANCE, FLU, COMPLEX, PEPTIDE, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, POLYMORPHISM, T-CELL, RECEPTOR
3skn:F (VAL5) to (GLU126) CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED | T CELL RECEPTOR, IMMUNE SYSTEM
1ct8:C (LEU2) to (ALA109) CATALYTIC ANTIBODY 7C8 COMPLEX | ABZYME TRANSITION STATE ANALOG, IMMUNE SYSTEM
2cdf:B (ASP4) to (GLU116) STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5E) | CELL RECEPTOR, CD1D, ALPHA-GALACTOSYLCERAMIDE, NON-CANONICAL TCR, TCR, T CELL RECEPTOR, MHC CLASS I, NATURAL KILLER T CELL, TCR 5E
2cdg:B (ASP4) to (GLU117) STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5B) | RECEPTOR, CD1D, MHC CLASS I, TCR 5B
2qhr:L (LEU3) to (GLY108) CRYSTAL STRUCTURE OF THE 13F6-1-2 FAB FRAGMENT BOUND TO ITS EBOLA VIRUS GLYCOPROTEIN PEPTIDE EPITOPE. | IMMUNOLOGLOBULIN FOLD, ANTIBODY-PEPTIDE COMPLEX, IMMUNE SYSTEM/VIRAL PROTEIN COMPLEX
4isv:A (LEU2) to (VAL114) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 1C2, A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE | 1C2,FAB, VLX, NEURODEGENERATION, POLYGLUTAMINE DISEASE, AMYLOID DISEASE, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
4j1u:E (VAL3) to (SER114) CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT | ANTIBODY MATURATION, ANTIBODY STABILITY, CLONAL SELECTION, IMMUNE SYSTEM
3tyf:D (ASP3) to (GLU118) CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR | IMMUNOGLOBULIN-LIKE, ANTIGEN RECOGNITION, CD1D, MEMBRANE, IMMUNE SYSTEM
4k3h:D (GLN1) to (LEU106) IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN | IMMUNOGLOBULIN FOLD, FLUORESCENSCE, MALACHITE GREEN, O-MANNOSYLATION, THR27, IMMUNE SYSTEM-INHIBITOR COMPLEX
2fec:L (ASP1) to (ALA108) STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI | CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN
1rz8:D (GLU1) to (SER112) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
4z7u:F (GLY3) to (GLU128) S13 COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4z7v:F (GLY3) to (GLU128) L3-12 COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4z7v:H (GLY3) to (GLU128) L3-12 COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
2vlj:D (GLN3) to (PRO111) THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, TCR, FLU, MHC, MHC I, T-CELL, COMPLEX
1shm:E (VAL2) to (VAL111) CONVERGENT SOLUTIONS TO VHH DOMAIN STABILIZATION FROM NATURAL AND IN VITRO EVOLUTION | HEAVY CHAIN VARIABLE DOMAIN, VHH DOMAIN, IMMUNOGLOBULIN, IMMUNE SYSTEM
2gk0:L (LEU2) to (ALA109) STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2 | IMMUNOGLOBULIN,CATALYTIC ANTIBODY, ELIMINATION, IMMUNE SYSTEM
3idi:B (ARG1) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ALDKWNQ | HIV-1, GP41, MPER, 2F5, IMMUNE SYSTEM
1tcr:B (ALA3) to (LEU116) MURINE T-CELL ANTIGEN RECEPTOR 2C CLONE | T-CELL, RECEPTOR, TRANSMEMBRANE, GLYCOPROTEIN
3vxm:E (VAL4) to (GLU114) THE COMPLEX BETWEEN C1-28 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE
2ial:A (ILE1) to (PRO108) STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED TCR | X-RAY CRYSTALLOGRAPHY, MAJOR HISTOCOMPATIBILITY COMPLEX, T CELL RECEPTOR, T CELL STIMULATION, MELANOMA, TUMOR ANTIGEN, IMMUNE SYSTEM
2icw:I (SER2) to (LEU110) CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR, SUPERANTIGEN, AND PEPTIDE-MHC CLASS II MOLECULE | TCR, MHC, SUPERANTIGEN, PROTEIN-PROTEIN COMPLEX, IMMUNE SYSTEM
2icw:K (SER2) to (LEU110) CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR, SUPERANTIGEN, AND PEPTIDE-MHC CLASS II MOLECULE | TCR, MHC, SUPERANTIGEN, PROTEIN-PROTEIN COMPLEX, IMMUNE SYSTEM
3j7e:L (VAL3) to (ALA115) ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS | HPV16.V5 FAB VARIABLE DOMAIN, HI AND FG LOOPS, HPV16 CAPSID, VIRUS- FAB COMPLEX, NEUTRALIZATION ANTIBODY, MATURATION, IMMUNE SYSTEM
3j7e:A (VAL3) to (ALA115) ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS | HPV16.V5 FAB VARIABLE DOMAIN, HI AND FG LOOPS, HPV16 CAPSID, VIRUS- FAB COMPLEX, NEUTRALIZATION ANTIBODY, MATURATION, IMMUNE SYSTEM
3j7e:C (VAL3) to (ALA115) ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS | HPV16.V5 FAB VARIABLE DOMAIN, HI AND FG LOOPS, HPV16 CAPSID, VIRUS- FAB COMPLEX, NEUTRALIZATION ANTIBODY, MATURATION, IMMUNE SYSTEM
3j7e:E (VAL3) to (ALA115) ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS | HPV16.V5 FAB VARIABLE DOMAIN, HI AND FG LOOPS, HPV16 CAPSID, VIRUS- FAB COMPLEX, NEUTRALIZATION ANTIBODY, MATURATION, IMMUNE SYSTEM
2xna:A (GLN2) to (PRO110) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN T CELL RECEPTOR AND STAPHYLOCOCCAL ENTEROTOXIN | IMMUNE SYSTEM, SUPERANTIGEN
5c09:D (GLU3) to (PRO111) HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
2nts:P (GLY3) to (GLU118) CRYSTAL STRUCTURE OF SEK-HVB5.1 | SUPERANTIGEN; T CELL RECEPTOR, TOXIN-IMMUNE SYSTEM COMPLEX
2nx5:J (GLY3) to (GLU118) CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A | TCR-PMHC, IMMUNE COMPLEX, IMMUNE SYSTEM
2nxz:D (GLU3001) to (SER3127) HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T257S, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2ny1:D (GLU3001) to (SER3127) HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C, T257S, S334A, S375W, Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2ny3:D (GLU3001) to (SER3127) HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E267C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3k81:B (GLN3) to (SER120) STRUCTURE OF THE CENTRAL INTERACTION PROTEIN FROM THE TRYPANOSOMA BRUCEI EDITOSOME IN COMPLEX WITH SINGLE DOMAIN ANTIBODIES | KREPA6, VHH, SINGLE DOMAIN ANTIBODY, IMMUNE SYSTEM, RNA BINDING PROTEIN
4onh:A (LYS1) to (HIS109) CRYSTAL STRUCTURE OF DN6 TCR | IG FOLD, TCR, ANTIGEN RECOGNITION, MHC LIKE, IMMUNE SYSTEM
2znw:B (ILE2) to (ILE106) CRYSTAL STRUCTURE OF SCFV10 IN COMPLEX WITH HEN EGG LYSOZYME | SINGLE CHAIN FV, LYSOZYME, ALLERGEN, ANTIMICROBIAL, BACTERIOLYTIC ENZYME, GLYCOSIDASE, HYDROLASE, IMMUNE SYSTEM-HYDROLASE COMPLEX
4p49:A (ALA1) to (LEU102) THE STRUCTURE OF A CHICKEN ANTI-PROSTATE SPECIFIC ANTIGEN SCFV | RECOMBINANT ANTIBODY, CHICKEN, CARDIAC TROPONIN I, SCFV, IMMUNOGLOBULIN, PHAGE DISPLAY, IMMUNE SYSTEM
4p4k:D (VAL4) to (GLU114) STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY | BE BOUND COMPLEX, CHRONIC BERYLLIUM DISEASE, TCR-MHC PEPTIDE-BE2+, IMMUNE SYSTEM
4p4k:H (GLY3) to (GLU114) STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY | BE BOUND COMPLEX, CHRONIC BERYLLIUM DISEASE, TCR-MHC PEPTIDE-BE2+, IMMUNE SYSTEM
4p5t:B (ALA1) to (GLU111) 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE | MHC, TCR, IMMUNE RECEPTOR, IG-LIKE DOMAIN, IMMUNE SYSTEM
4p5t:F (ALA1) to (LEU110) 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE | MHC, TCR, IMMUNE RECEPTOR, IG-LIKE DOMAIN, IMMUNE SYSTEM
3kr3:L (GLN4) to (THR110) CRYSTAL STRUCTURE OF IGF-II ANTIBODY COMPLEX | ANTIBODY-TARGET COMPLEX, CARBOHYDRATE METABOLISM, GLUCOSE METABOLISM, GLYCOPROTEIN, GROWTH FACTOR, HORMONE, MITOGEN, OSTEOGENESIS, SECRETED, IMMUNE SYSTEM
5d7l:D (LYS3) to (PRO109) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR | RECEPTOR, ANTIGEN, IMMUNE SYSTEM
5d8j:H (VAL2) to (SER118) DEVELOPMENT OF A THERAPEUTIC MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT TYPE 2 DIABETES. | AP2, FABP4, DIABETES, METABOLIC SYNDROME, IMMUNE SYSTEM
1mwa:B (ALA2) to (GLU117) 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX | IG DOMAIN, ANTIGEN RECOGNITION, COMPLEMENTARITY DETERMINING REGION, IMMUNE SYSTEM
3kyk:L (GLN3) to (THR109) CRYSTAL STRUCTURE OF LI33 IGG1 FAB | ANTIBODY, IMMUNE SYSTEM
1yzz:A (VAL2) to (VAL116) HUMANIZED CABAN33 AT ROOM TEMPERATURE | ANTIBODY, CAMEL ANTIBODY, HUMANIZATION, UNKNOWN FUNCTION
5dr5:L (ASP1) to (THR110) CRYSTAL STRUCTURE OF THE SCLEROSTIN-NEUTRALIZING FAB ABD09097 | SCLEROSTIN-NEUTRALIZING, FAB, WNT INHIBITOR, IMMUNE SYSTEM
3mbe:D (ALA3) to (GLU128) TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27) | T CELL RECEPTOR, HISTOCOMPATABILITY ANTIGEN, MHC CLASS II, I-AG7, IMMUNE SYSTEM
3mbe:H (ALA3) to (GLU128) TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27) | T CELL RECEPTOR, HISTOCOMPATABILITY ANTIGEN, MHC CLASS II, I-AG7, IMMUNE SYSTEM
3mff:B (LYS3) to (GLU115) 1F1E8HU TCR | T-CELL RECEPTOR, PROTEIN METAMORPHISM, ALPHA CONSTANT DOMAIN, IMMUNE SYSTEM
3mff:D (LYS3) to (GLU115) 1F1E8HU TCR | T-CELL RECEPTOR, PROTEIN METAMORPHISM, ALPHA CONSTANT DOMAIN, IMMUNE SYSTEM
4qok:D (GLU5) to (GLN112) STRUCTURAL BASIS FOR INEFFECTIVE T-CELL RESPONSES TO MHC ANCHOR RESIDUE IMPROVED HETEROCLITIC PEPTIDES | IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM
5eor:L (LEU3) to (GLY117) STRUCTURE OF THE MURINE ANTIBODY FAB 8E3 BOUND TO THE VACCINIA VIRUS A27 PEPTIDE 101-110 | ANTIBODY, FAB, VACCINIA VIRUS, NEUTRALIZING, LINEAR EPITOPE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4qrp:L (VAL4) to (GLU128) CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR | HLA B*0801, HUAMN HEPATITIS C VIRUS, TCR, T CELL, IMMUNE SYSTEM
4qrr:E (GLY3) to (GLU128) CRYSTAL STRUCTURE OF HLA B*3501-IPS IN COMPLEX WITH A DELTA-BETA TCR, CLONE 12 TCR | HLA B*3501, HUAMN CMV, TCR, T CELL, IMMUNE SYSTEM
3bt2:L (ASP1) to (ILE106) STRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX | PROTEIN-PROTEIN INTERACTION, GLYCOPROTEIN, GPI-ANCHOR, LIPOPROTEIN, MEMBRANE, RECEPTOR, SECRETED, BLOOD COAGULATION, EGF-LIKE DOMAIN, FIBRINOLYSIS, HYDROLASE, KRINGLE, PHOSPHOPROTEIN, PLASMINOGEN ACTIVATION, PROTEASE, SERINE PROTEASE, ZYMOGEN, CELL ADHESION, HEPARIN-BINDING, SULFATION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
5ff6:C (ILE2) to (THR109) CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
3o6f:D (VAL1) to (GLU115) CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4 | AUTOIMMUNITY, MULTIPLE SCLEROSIS, T CELL RECEPTOR, HLA CLASS II, PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBULIN FOLD, MEMBRANE, IMMUNE SYSTEM
3o6f:H (VAL1) to (GLU115) CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4 | AUTOIMMUNITY, MULTIPLE SCLEROSIS, T CELL RECEPTOR, HLA CLASS II, PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBULIN FOLD, MEMBRANE, IMMUNE SYSTEM
3d85:A (ILE2) to (THR109) CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB | INTERLEUKIN-23, FAB, IMMUNE SYSTEM/CYTOKINE COMPLEX
3of6:C (GLY3) to (GLU118) HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE | IG FOLD, IMMUNE SYSTEM
4e42:B (VAL2) to (GLU110) STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4 | IG DOMAIN, ADAPTIVE IMMUNITY, T CELL RECEPTOR, MHC, IMMUNE SYSTEM
4e42:D (VAL2) to (GLU110) STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4 | IG DOMAIN, ADAPTIVE IMMUNITY, T CELL RECEPTOR, MHC, IMMUNE SYSTEM
4ei6:D (LYS3) to (GLU115) STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR | NATURAL KILLER T CELL RECEPTOR, IMMUNE SYSTEM
3q5y:A (GLY3) to (GLU117) V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES | IG, T CELL RECEPTOR, ANTIGEN PEPTIDE/MHC, MEMBRANE, IMMUNE SYSTEM
3q5y:B (VAL4) to (GLU117) V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES | IG, T CELL RECEPTOR, ANTIGEN PEPTIDE/MHC, MEMBRANE, IMMUNE SYSTEM
3q5y:C (VAL4) to (GLU117) V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES | IG, T CELL RECEPTOR, ANTIGEN PEPTIDE/MHC, MEMBRANE, IMMUNE SYSTEM
3q5y:D (GLY3) to (GLU117) V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES | IG, T CELL RECEPTOR, ANTIGEN PEPTIDE/MHC, MEMBRANE, IMMUNE SYSTEM
3rgv:B (ALA1) to (LEU110) A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS | TCR, MHC, MHC CLASS I, IMMUNE SYSTEM
4g8e:B (GLY3) to (GLU133) CRYSTAL STRUCTURE OF CLONE18 TCR | TCR, T CELL, CD1B, GMM, LIPID RECOGNITION, IMMUNE SYSTEM
4glr:K (ALA3) to (GLY107) STRUCTURE OF THE ANTI-PTAU FAB (PT231/PS235_1) IN COMPLEX WITH PHOSPHOEPITOPE PT231/PS235 | IGG1 FAB, ANTI-PTAU ANTIBODY, PHOSPHORYLATED TAU PEPTIDE, PHOSPHORYLATION, IMMUNE SYSTEM
5ks9:E (GLN9) to (PRO128) BEL502-DQ8-GLIA-ALPHA1 COMPLEX | CELIAC DISEASE T CELL RECEPTOR PEPTIDE MHC COMPLEX, IMMUNE SYSTEM
5ks9:F (GLY3) to (GLU128) BEL502-DQ8-GLIA-ALPHA1 COMPLEX | CELIAC DISEASE T CELL RECEPTOR PEPTIDE MHC COMPLEX, IMMUNE SYSTEM
5ks9:G (GLN9) to (PRO128) BEL502-DQ8-GLIA-ALPHA1 COMPLEX | CELIAC DISEASE T CELL RECEPTOR PEPTIDE MHC COMPLEX, IMMUNE SYSTEM
5ksa:D (GLY3) to (GLU128) BEL602-DQ8.5-GLIA-GAMMA1 COMPLEX | CELIAC DISEASE T CELL RECEPTOR PEPTIDE MHC COMPLEX, IMMUNE SYSTEM
5ksb:E (GLN3) to (PRO128) T15-DQ8.5-GLIA-GAMMA1 COMPLEX | CELIAC DISEASE T CELL RECEPTOR PEPTIDE MHC COMPLEX, IMMUNE SYSTEM
5ksb:H (GLY3) to (GLU128) T15-DQ8.5-GLIA-GAMMA1 COMPLEX | CELIAC DISEASE T CELL RECEPTOR PEPTIDE MHC COMPLEX, IMMUNE SYSTEM
5l2k:E (GLY3) to (GLU127) CRYSTAL STRUCTURE OF GEM42 TCR-CD1B-GMM COMPLEX | CD1B, LIPID, TB, MTB, GMM, TUBERCULOSIS, GEM T CELL, TCR, T CELL, GEM42, IMMUNE SYSTEM
5swz:E (VAL4) to (GLU127) CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX | H2DB, INFLUENZA, NP366, REVERSED DOCKING, NAIVE T CELL, NP1-B17 TCR, TCR, T CELL, IMMUNE SYSTEM
5t5f:H (VAL2) to (VAL120) NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5 | FHBP, JAR5, EPITOPE MAPPING, MONOCLONAL ANTIBODY, COOPERATIVITY, NEISSERIA MENINGITIDIS, PROTEIN BINDING
1nfd:C (ASP1) to (ALA116) AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY | COMPLEX (IMMUNORECEPTOR-IMMUNOGLOBULIN), COMPLEX (IMMUNORECEPTOR- IMMUNOGLOBULIN) COMPLEX
2pyf:B (GLY1) to (GLU112) CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY UNBOUND TCR CLONE 5-1 | T-CELL RECEPTOR, CDR3, PHAGE DISPLAY, MUTANT, HIGH AFFINITY, NY-ESO- 1, IMMUNE SYSTEM
1gc1:H (GLN1) to (THR127) HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY | COMPLEX (HIV ENVELOPE PROTEIN-CD4-FAB), HIV-1 EXTERIOR ENVELOPE GP120, T-CELL SURFACE GLYCOPROTEIN CD4, ANTIGEN-BINDING FRAGMENT OF HUMAN IMMUNOGLOBULIN 17B, GLYCOSYLATED PROTEIN, VIRAL PROTEIN- RECEPTOR-IMMUNE SYSTEM COMPLEX
2wbj:D (GLY23) to (GLU141) TCR COMPLEX | TRANSMEMBRANE, IMMUNE RESPONSE, T CELL RECEPTOR, MHC II, MEMBRANE, RECEPTOR, MOLECULAR MIMICRY, MULTIPLE SCLEROSIS, IMMUNE SYSTEM, AUTOIMMUNITY, GLYCOPROTEIN, MHC CLASS II
3vxq:E (VAL4) to (LEU113) H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10 | HIV-1, NEF, IMMUNE SYSTEM, T CELL RECEPTOR, IMMUNOGLOBURIN DOMAIN, TCR, IMMUNE RESPONSE
3vxq:B (VAL4) to (GLU114) H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10 | HIV-1, NEF, IMMUNE SYSTEM, T CELL RECEPTOR, IMMUNOGLOBURIN DOMAIN, TCR, IMMUNE RESPONSE
4p23:B (ALA1) to (GLU111) J809.B5 TCR BOUND TO IAB/3K | TCR MHC PEPTIDE, IMMUNE SYSTEM
4prp:D (GLN3) to (PRO128) CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:01-HPVG-Q5 COMPLEX | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM
3mlv:M (SER1) to (LEU110) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3byt:G (ALA3) to (LEU117) A COMPLEX BETWEEN A VARIANT OF STAPHYLOCOCCAL ENTEROTOXIN C3 AND THE VARIABLE DOMAIN OF THE MURINE T CELL RECEPTOR BETA CHAIN 8.2 | SECRETED, SUPERANTIGEN, TOXIN
4e41:I (ILE1) to (PRO109) STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4 | IG DOMAIN, ADAPTIVE IMMUNITY, T CELL RECEPTOR, MHC, IMMUNE SYSTEM